V. A. Bhadkamkar

1.0k total citations
20 papers, 810 citations indexed

About

V. A. Bhadkamkar is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, V. A. Bhadkamkar has authored 20 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in V. A. Bhadkamkar's work include Radiopharmaceutical Chemistry and Applications (9 papers), Prostate Cancer Treatment and Research (8 papers) and Prostate Cancer Diagnosis and Treatment (6 papers). V. A. Bhadkamkar is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (9 papers), Prostate Cancer Treatment and Research (8 papers) and Prostate Cancer Diagnosis and Treatment (6 papers). V. A. Bhadkamkar collaborates with scholars based in United States, France and United Kingdom. V. A. Bhadkamkar's co-authors include R. Joseph Babaian, Herbert A. Fritsche, Patricia Troncoso, John W. Davis, Hiroyuki Nakanishi, Donald A. Podoloff, Harry G. Rittenhouse, Leela P. Kasi, Jack Groskopf and Amy Blase and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Journal of Urology.

In The Last Decade

V. A. Bhadkamkar

20 papers receiving 785 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
V. A. Bhadkamkar United States	13	484	224	218	173	150	20	810
Özer Algan United States	16	344 0.7×	103 0.5×	193 0.9×	117 0.7×	84 0.6×	56	753
Savvas Papadopoulos Greece	14	248 0.5×	389 1.7×	88 0.4×	157 0.9×	156 1.0×	41	659
Connor J. Kinslow United States	13	463 1.0×	189 0.8×	59 0.3×	287 1.7×	328 2.2×	40	871
Jean‐Baptiste Méric France	14	285 0.6×	244 1.1×	106 0.5×	70 0.4×	184 1.2×	28	620
Monika Jermann Switzerland	7	398 0.8×	214 1.0×	86 0.4×	206 1.2×	138 0.9×	11	645
Gianluca Ingrosso Italy	17	726 1.5×	176 0.8×	408 1.9×	151 0.9×	73 0.5×	75	1.0k
Albiruni Abdul Razak Canada	12	267 0.6×	425 1.9×	73 0.3×	98 0.6×	138 0.9×	37	726
Martin C. Tom United States	14	329 0.7×	139 0.6×	118 0.5×	140 0.8×	86 0.6×	68	629
Robert T. Maguire United States	11	458 0.9×	149 0.7×	305 1.4×	37 0.2×	148 1.0×	22	793
Siobhan Ng Australia	12	360 0.7×	355 1.6×	169 0.8×	77 0.4×	119 0.8×	33	708

Countries citing papers authored by V. A. Bhadkamkar

Since Specialization

Citations

This map shows the geographic impact of V. A. Bhadkamkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. A. Bhadkamkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. A. Bhadkamkar more than expected).

Fields of papers citing papers by V. A. Bhadkamkar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. A. Bhadkamkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. A. Bhadkamkar. The network helps show where V. A. Bhadkamkar may publish in the future.

Co-authorship network of co-authors of V. A. Bhadkamkar

This figure shows the co-authorship network connecting the top 25 collaborators of V. A. Bhadkamkar. A scholar is included among the top collaborators of V. A. Bhadkamkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. A. Bhadkamkar. V. A. Bhadkamkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Nakanishi, Hiroyuki, Jack Groskopf, Herbert A. Fritsche, et al.. (2008). PCA3 Molecular Urine Assay Correlates With Prostate Cancer Tumor Volume: Implication in Selecting Candidates for Active Surveillance. The Journal of Urology. 179(5). 1804–1810. 217 indexed citations

2.

Ochiai, Atsushi, et al.. (2008). Natural History of Biochemical Progression After Radical Prostatectomy Based on Length of a Positive Margin. Urology. 71(2). 308–312. 44 indexed citations

3.

Davis, John W., Hiroyuki Nakanishi, Vikas Kumar, et al.. (2008). Circulating Tumor Cells in Peripheral Blood Samples From Patients With Increased Serum Prostate Specific Antigen: Initial Results in Early Prostate Cancer. The Journal of Urology. 179(6). 2187–2191. 112 indexed citations

4.

Ochiai, Atsushi, Ashish Shukla, John W. Davis, et al.. (2007). Is There a Role for Serum Human Tissue Kallikrein in Detection of Prostate Cancer?. Urology. 70(3). 519–522. 3 indexed citations

5.

Naya, Yoshio, Herbert A. Fritsche, V. A. Bhadkamkar, et al.. (2005). Evaluation of precursor prostate-specific antigen isoform ratios in the detection of prostate cancer. Urologic Oncology Seminars and Original Investigations. 23(1). 16–21. 21 indexed citations

6.

Naya, Yoshio, Herbert A. Fritsche, V. A. Bhadkamkar, et al.. (2004). Volume-based evaluation of serum assays for new prostate-specific antigen isoforms in the detection of prostate cancer. Urology. 63(3). 492–498. 10 indexed citations

7.

Cohen, Lorenzo, Rachel T. Fouladi, Richard J. Babaian, et al.. (2003). Cancer worry is associated with abnormal prostate-specific antigen levels in men participating in a community screening program.. PubMed. 12(7). 610–7. 25 indexed citations

8.

Mian, Badar M., Patricia Troncoso, Koji Okihara, et al.. (2002). Outcome Of Patients With Gleason Score 8 Or Higher Prostate Cancer Following Radical Prostatectomy Alone. The Journal of Urology. 1675–1680. 1 indexed citations

9.

Mian, Badar M., Patricia Troncoso, Koji Okihara, et al.. (2002). Outcome Of Patients With Gleason Score 8 Or Higher Prostate Cancer Following Radical Prostatectomy Alone. The Journal of Urology. 167(4). 1675–1680. 64 indexed citations

10.

Blend, Michael J. & V. A. Bhadkamkar. (1998). Impact of Radioimmunoscintigraphy on the Management of Colorectal and Ovarian Cancer Patients: A Retrospective Study. Cancer Investigation. 16(7). 431–441. 8 indexed citations

11.

Sirisriro, Rojana, Donald A. Podoloff, Yehuda Z. Patt, et al.. (1996). 99Tcm-IMMU4 imaging in recurrent colorectal cancer. Nuclear Medicine Communications. 17(7). 568–576. 9 indexed citations

12.

Delpassand, Ebrahim S., J.R. García, V. A. Bhadkamkar, & Donald A. Podoloff. (1995). Value of SPECT Imaging of the Thoracolumbar Spine in Cancer Patients. Clinical Nuclear Medicine. 20(12). 1047–1051. 24 indexed citations

13.

Murray, James L., Daniel J. Macey, Michael G. Rosenblum, et al.. (1995). Enhanced TAG-72 expression and tumor uptake of radiolabeled monoclonal antibody CC49 in metastatic breast cancer patients following alpha-interferon treatment.. PubMed. 55(23 Suppl). 5925s–5928s. 32 indexed citations

14.

Patt, Yehuda Z., Donald A. Podoloff, Steven A. Curley, et al.. (1994). Technetium 99m-labeled IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging of occult recurrent colorectal cancer in patients with rising serum carcinoembryonic antigen levels.. Journal of Clinical Oncology. 12(3). 489–495. 22 indexed citations

15.

Rosenblum, Michael G., Hua-Zhong Zhang, Donald A. Podoloff, et al.. (1994). Comparative tumor localization of whole immunoglobulin g anticarcinoembryonic antigen monoclonal antibodies immu-4 and immu-4 f(ab′)2 in colorectal cancer patients. Cancer. 73(S3). 850–857. 14 indexed citations

16.

Murray, James L., Joan E. Cunningham, Kalpana Mujoo, et al.. (1994). Phase I trial of murine monoclonal antibody 14G2a administered by prolonged intravenous infusion in patients with neuroectodermal tumors.. Journal of Clinical Oncology. 12(1). 184–193. 86 indexed citations

17.

Murray, James L., Daniel J. Macey, Leela P. Kasi, et al.. (1994). Phase II radioimmunotherapy trial with131I-CC49 in colorectal cancer. Cancer. 73(S3). 1057–1066. 75 indexed citations

18.

Rosenblum, Michael G., Daniel J. Macey, Donald A. Podoloff, et al.. (1993). A phase I pharmacokinetic, toxicity and dosimetry study of 131I labeled IMMU-4 F(ab')2 in patients with advanced colorectal carcinoma. 6(4). 239–255. 3 indexed citations

19.

Podoloff, Donald A., et al.. (1992). 99mTc SESTAMIBI IN THE EVALUATION OF NEOPLASTIC DISEASE. Clinical Nuclear Medicine. 17(3). 253–253. 2 indexed citations

20.

Lamki, L., Aman U. Buzdar, S. Eva Singletary, et al.. (1991). Indium-111-labeled B72.3 monoclonal antibody in the detection and staging of breast cancer: a phase I study.. PubMed. 32(7). 1326–32. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact